UB Paderborn / Katalog / Suche / in CDI

Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)

Annals of oncology, 2016-07, Vol.27 (7), p.1299-1304

2016

Volltextzugriff (PDF)

One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group

Annals of oncology, 2014-11, Vol.25 (11), p.2167-2172

2014

Volltextzugriff (PDF)

Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: A nationwide population-based study in Sweden

European journal of cancer (1990), 2013-08, Vol.49 (12), p.2705-2716

2013

Volltextzugriff (PDF)

Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men

British journal of dermatology (1951), 2015-03, Vol.172 (3), p.700-706

2015

Volltextzugriff (PDF)

Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study

Annals of oncology, 2010-09, Vol.21 (9), p.1858-1863

2010

Volltextzugriff (PDF)

Phase II multicenter open label study of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study)

ANNALS OF ONCOLOGY, 2019, Vol.30, p.v907

2019

Volltextzugriff (PDF)

Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2b

European journal of cancer (1990), 2012-09, Vol.48 (13), p.2012-2019

2012

Volltextzugriff (PDF)

Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register

British journal of dermatology (1951), 2013-04, Vol.168 (4), p.779-786

2013

Volltextzugriff (PDF)

Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients

British journal of cancer, 2003-08, Vol.89 (3), p.460-464

2003

Volltextzugriff (PDF)

The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma

Nature communications, 2021-08, Vol.12 (1), p.5155-10, Article 5155

2021

Volltextzugriff (PDF)

1303 POSTER Sequential Therapy and Immortal Time Bias in Register Studies

European journal of cancer (1990), 2011, Vol.47, p.S164-S164

2011

Volltextzugriff (PDF)

Feelings of loss and uneasiness or shame after removal of a testicle by orchidectomy: a population-based long-term follow-up of testicular cancer survivors

International journal of andrology, 2011-04, Vol.34 (2), p.183-192

2011

Volltextzugriff (PDF)

7111 POSTER DISCUSSION High-dose Chemotherapy With Autologous Stem-cell Support in Patients With Metastatic Non-seminomatous Testicular Cancer -a Report From the Swedish Norwegian Testicular Cancer Group (SWENOTECA)

European journal of cancer (1990), 2011, Vol.47, p.S507-S508

2011

Volltextzugriff (PDF)

Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study

BMC cancer, 2019-05, Vol.19 (1), p.415-415, Article 415

2019

Volltextzugriff (PDF)

POD-6.05: Treatment of Metastatic Renal Cell Carcinoma by Peginterferon Alfa-2b

Urology (Ridgewood, N.J.), 2008, Vol.72 (5), p.S51-S52

2008

Volltextzugriff (PDF)

Noninvasive detection of any-stage cancer using free glycosaminoglycans

Proceedings of the National Academy of Sciences - PNAS, 2022-12, Vol.119 (50), p.e2115328119-e2115328119

2022

Volltextzugriff (PDF)

Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma

The New England journal of medicine, 2012-07, Vol.367 (2), p.107-114

2012

Volltextzugriff (PDF)

Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program

Journal of clinical oncology, 2009-05, Vol.27 (13), p.2122-2128

2009

Volltextzugriff (PDF)

A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma

Cell death & disease, 2018-07, Vol.9 (8), p.810, Article 810

2018

Volltextzugriff (PDF)

Urine free glycosaminoglycans as monitoring biomarkers in confined renal cell carcinoma - A prospective observational study

European Urology, 2021, Vol.79, p.S900

2021

Volltextzugriff (PDF)

POD-6.04: Evaluation of Sorafenib Treatment in Metastatic Renal Cell Carcinoma with Positron Emission Tomography

Urology (Ridgewood, N.J.), 2008, Vol.72 (5), p.S51-S51

2008

Volltextzugriff (PDF)

Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program (vol 27, pg 2122, 2009)

Journal of clinical oncology, 2009-07, Vol.27 (19), p.3263

2009

Volltextzugriff (PDF)

The melanoma incidence continues to rise

Läkartidningen, 2017, Vol.114

2017

Volltextzugriff (PDF)

Health-related quality of life (HRQOL) in the Nordic randomized trial of adjuvant intermediate-dose interferon alfa-2b in high-risk melanoma

JOURNAL OF CLINICAL ONCOLOGY, 2011, Vol.29 (15_suppl), p.8547-8547

2011

Volltextzugriff (PDF)

Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial

The lancet oncology, 2011-02, Vol.12 (2), p.144-152

2011

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)

One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group

Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: A nationwide population-based study in Sweden

Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men

Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study

Phase II multicenter open label study of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study)

Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2b

Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register

Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients

The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma

1303 POSTER Sequential Therapy and Immortal Time Bias in Register Studies

Feelings of loss and uneasiness or shame after removal of a testicle by orchidectomy: a population-based long-term follow-up of testicular cancer survivors

7111 POSTER DISCUSSION High-dose Chemotherapy With Autologous Stem-cell Support in Patients With Metastatic Non-seminomatous Testicular Cancer -a Report From the Swedish Norwegian Testicular Cancer Group (SWENOTECA)

Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study

POD-6.05: Treatment of Metastatic Renal Cell Carcinoma by Peginterferon Alfa-2b

Noninvasive detection of any-stage cancer using free glycosaminoglycans

Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma

Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program

A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma

Urine free glycosaminoglycans as monitoring biomarkers in confined renal cell carcinoma - A prospective observational study

POD-6.04: Evaluation of Sorafenib Treatment in Metastatic Renal Cell Carcinoma with Positron Emission Tomography

Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program (vol 27, pg 2122, 2009)

The melanoma incidence continues to rise

Health-related quality of life (HRQOL) in the Nordic randomized trial of adjuvant intermediate-dose interferon alfa-2b in high-risk melanoma

Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial

Suchergebnisse filtern